The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands

scientific article (publication date: 2014)

The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands is …
instance of (P31):
scholarly articleQ13442814

External links are
P8978DBLP publication IDjournals/nar/PawsonSBFABDMPSSYHN14
P356DOI10.1093/NAR/GKT1143
P3181OpenCitations bibliographic resource ID281297
P932PMC publication ID3965070
P698PubMed publication ID24234439
P5875ResearchGate publication ID262045204

P50authorHelen E BensonQ55475662
Elena FaccendaQ55475664
Joanna L. SharmanQ55475667
Christopher SouthanQ28133217
Michael SpeddingQ42388779
Adam J PawsonQ42660485
Steve AlexanderQ42922475
Anthony P DavenportQ43161913
P2093author name stringAnthony J Harmar
John A Peters
John C McGrath
NC-IUPHAR
O Peter Buneman
Wenyuan Yu
P2860cites workNovelty in the target landscape of the pharmaceutical industryQ57338670
Open Babel: An open chemical toolboxQ21198766
IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channelsQ24259024
The Protein Data BankQ24515306
Genenames.org: the HGNC resources in 2013Q24595108
International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligandsQ24605072
DrugBank 3.0: a comprehensive resource for 'omics' research on drugsQ24612505
From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resourceQ24632079
Chemical Entities of Biological Interest: an updateQ24644887
HMDB: a knowledgebase for the human metabolomeQ24655295
BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinitiesQ24675698
Open PHACTS: semantic interoperability for drug discoveryQ27061937
Recent Developments of the Chemistry Development Kit (CDK) - An Open-Source Java Library for Chemo- and BioinformaticsQ27065423
PubChem: Integrated Platform of Small Molecules and Biological ActivitiesQ28111978
International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacologyQ28189543
How many drug targets are there?Q28276660
Ensembl 2013Q28280494
ChEMBL: a large-scale bioactivity database for drug discoveryQ28315179
The Rat Genome Database 2013--data, tools and usersQ28677199
ChemSpider: An Online Chemical Information ResourceQ28842739
Analysis of in vitro bioactivity data extracted from drug discovery literature and patents: Ranking 1654 human protein targets by assayed compounds and molecular scaffoldsQ29042705
IUPHAR-DB: new receptors and tools for easy searching and visualization of pharmacological dataQ29043128
KEGG for integration and interpretation of large-scale molecular data setsQ29547277
ZINC: a free tool to discover chemistry for biologyQ29615857
Update on activities at the Universal Protein Resource (UniProt) in 2013Q29617361
International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclatureQ30429523
IUPHAR-DB: updated database content and new featuresQ30485756
CD-HIT Suite: a web server for clustering and comparing biological sequencesQ33686347
Trends in the exploitation of novel drug targetsQ34205159
Guide to Receptors and Channels (GRAC), 5th editionQ34228968
The Mouse Genome Database (MGD): comprehensive resource for genetics and genomics of the laboratory mouseQ35630854
Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery.Q35631111
International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers.Q36747895
Comparing the Chemical Structure and Protein Content of ChEMBL, DrugBank, Human Metabolome Database and the Therapeutic Target DatabaseQ37564801
New concepts in pharmacological efficacy at 7TM receptors: IUPHAR review 2.Q38044984
The druggable genome: Evaluation of drug targets in clinical trials suggests major shifts in molecular class and indicationQ38135497
Mapping between databases of compounds and protein targetsQ38467407
P275copyright licenseCreative Commons Attribution 3.0 UnportedQ14947546
P6216copyright statuscopyrightedQ50423863
P433issueDatabase issue
P407language of work or nameEnglishQ1860
P921main subjectpharmacologyQ128406
knowledge baseQ593744
IUPHAR/BPS Guide to PHARMACOLOGYQ17091219
P304page(s)D1098-106
P577publication date2014-01-01
P1433published inNucleic Acids ResearchQ135122
P1476titleThe IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
P478volume42

Reverse relations

cites work (P2860)
Q39786582'Partial' competition of heterobivalent ligand binding may be mistaken for allosteric interactions: a comparison of different target interaction models.
Q34954139(4-[6-(4-isopropoxyphenyl)pyrazolo [1,5-a]pyrimidin-3-yl] quinoline) is a novel inhibitor of autophagy
Q3601642215-Lipoxygenases regulate the production of chemokines in human lung macrophages
Q346194561E7-03, a low MW compound targeting host protein phosphatase-1, inhibits HIV-1 transcription
Q352864273,3'-Diindolylmethane attenuates LPS-mediated acute liver failure by regulating miRNAs to target IRAK4 and suppress Toll-like receptor signalling
Q412341803-Iodothyroacetic acid lacks thermoregulatory and cardiovascular effects in vivo
Q352239663-iodothyroacetic acid, a metabolite of thyroid hormone, induces itch and reduces threshold to noxious and to painful heat stimuli in mice
Q431015084-bromopropofol decreases action potential generation in spinal neurons by inducing a glycine receptor-mediated tonic conductance
Q422442335-HT3 receptors promote colonic inflammation via activation of substance P/neurokinin-1 receptors in dextran sulphate sodium-induced murine colitis
Q390046817TM Domain Structure of Adhesion GPCRs
Q399597589-Phenanthrol inhibits recombinant and arterial myocyte TMEM16A channels
Q63869261A Bayesian framework that integrates multi-omics data and gene networks predicts risk genes from schizophrenia GWAS data
Q37318955A Cell-type-resolved Liver Proteome
Q27021865A Molecular Pharmacologist's Guide to G Protein-Coupled Receptor Crystallography
Q35865445A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis
Q39026969A comprehensive map of molecular drug targets.
Q88977270A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
Q35865441A derivative of epigallocatechin-3-gallate induces apoptosis via SHP-1-mediated suppression of BCR-ABL and STAT3 signalling in chronic myelogenous leukaemia
Q34571412A formyl peptide receptor agonist suppresses inflammation and bone damage in arthritis
Q92376994A genome-wide positioning systems network algorithm for in silico drug repurposing
Q36935210A genomic case study of mixed fibrolamellar hepatocellular carcinoma
Q28647441A large-scale crop protection bioassay data set
Q102371658A ligand-based computational drug repurposing pipeline using KNIME and Programmatic Data Access: case studies for rare diseases and COVID-19
Q36342127A metabolite of Danshen formulae attenuates cardiac fibrosis induced by isoprenaline, via a NOX2/ROS/p38 pathway
Q35911730A molecular characterization of the agonist binding site of a nematode cys-loop GABA receptor
Q101406945A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19
Q35305286A new crystal structure fragment-based pharmacophore method for G protein-coupled receptors
Q34516513A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells
Q34914262A non-erythropoietic peptide derivative of erythropoietin decreases susceptibility to diet-induced insulin resistance in mice
Q34954047A novel 1,2-benzenediamine derivative FC-99 suppresses TLR3 expression and ameliorates disease symptoms in a mouse model of sepsis
Q35693015A novel CGRP-neutralizing Spiegelmer attenuates neurogenic plasma protein extravasation
Q41771681A novel approach to inhibit bone resorption: exosite inhibitors against cathepsin K
Q35039225A novel compound VSC2 has anti-inflammatory and antioxidant properties in microglia and in Parkinson's disease animal model
Q36036244A novel insulinotropic mechanism of whole grain-derived γ-oryzanol via the suppression of local dopamine D2 receptor signalling in mouse islet
Q28390721A novel mechanism for cytoprotection against hypoxic injury: δ-opioid receptor-mediated increase in Nrf2 translocation
Q43200676A novel multi-parameter assay to dissect the pharmacological effects of different modes of integrin αLβ2 inhibition in whole blood.
Q36941275A novel protein tyrosine phosphatase 1B inhibitor with therapeutic potential for insulin resistance
Q35538543A novel selective and orally bioavailable Nav 1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitability
Q35911764A novel snake venom-derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury
Q41295446A polyspecific drug/proton antiporter mediates diphenhydramine and clonidine transport at the mouse blood-retinal barrier.
Q28077631A review of the new HGNC gene family resource
Q35692995A store-operated calcium channel inhibitor attenuates collagen-induced arthritis
Q38240756A-kinase anchoring proteins: cAMP compartmentalization in neurodegenerative and obstructive pulmonary diseases
Q35842234A-kinase-anchoring proteins coordinate inflammatory responses to cigarette smoke in airway smooth muscle
Q35484325A6V polymorphism of the human μ-opioid receptor decreases signalling of morphine and endogenous opioids in vitro.
Q35484505AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner
Q38411332APT070 (mirococept), a membrane-localizing C3 convertase inhibitor, attenuates early human islet allograft damage in vitro and in vivo in a humanized mouse model
Q35111465AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation
Q35223957AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology
Q56762858Accessing Expert-Curated Pharmacological Data in the IUPHAR/BPS Guide to PHARMACOLOGY
Q36394989Actions of KMUP-1, a xanthine and piperazine derivative, on voltage-gated Na(+) and Ca(2+) -activated K(+) currents in GH3 pituitary tumour cells
Q36744213Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model
Q36124238Activating mitochondrial function and haemoglobin expression with EH-201, an inducer of erythropoietin in neuronal cells, reverses memory impairment
Q36036213Activation of EP4 receptors prevents endotoxin-induced neutrophil infiltration into the airways and enhances microvascular barrier function
Q36342084Activation of M3 cholinoceptors attenuates vascular injury after ischaemia/reperfusion by inhibiting the Ca2+/calmodulin-dependent protein kinase II pathway
Q35846222Activation of NALP1 inflammasomes in rats with adjuvant arthritis; a novel therapeutic target of carboxyamidotriazole in a model of rheumatoid arthritis
Q35911725Activation of PPAR-δ induces microRNA-100 and decreases the uptake of very low-density lipoprotein in endothelial cells
Q38254275Activation of PPARδ: from computer modelling to biological effects.
Q36342122Activation of TRPV1 attenuates high salt-induced cardiac hypertrophy through improvement of mitochondrial function
Q37686124Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches
Q28611248Activity, assay and target data curation and quality in the ChEMBL database
Q35865452Acute morphine affects the rat circadian clock via rhythms of phosphorylated ERK1/2 and GSK3β kinases and Per1 expression in the rat suprachiasmatic nucleus
Q41842140Addition of a single methyl group to a small molecule sodium channel inhibitor introduces a new mode of gating modulation
Q42412786Adenosine A(2A) receptors are necessary and sufficient to trigger memory impairment in adult mice.
Q36744187Adenosine A1 receptor activation attenuates cardiac hypertrophy and fibrosis in response to α1 -adrenoceptor stimulation in vivo.
Q36797394Adrenaline: insights into its metabolic roles in hypoglycaemia and diabetes
Q36342169Advances in exploring the role of microRNAs in the pathogenesis, diagnosis and therapy of cardiac diseases in China
Q36342155Advances in receptor conformation research: the quest for functionally selective conformations focusing on the β2-adrenoceptor
Q35978097Agonist- and antagonist-induced up-regulation of surface 5-HT3 A receptors.
Q41908015Alcohol enhances the psychostimulant and conditioning effects of mephedrone in adolescent mice; postulation of unique roles of D3 receptors and BDNF in place preference acquisition.
Q36342150Aldosterone down-regulates the slowly activated delayed rectifier potassium current in adult guinea pig cardiomyocytes
Q36211232Alkaline phosphatase protects against renal inflammation through dephosphorylation of lipopolysaccharide and adenosine triphosphate.
Q37686126All-trans retinoic acid protects against doxorubicin-induced cardiotoxicity by activating the ERK2 signalling pathway
Q35978091Allosteric modulation of sigma-1 receptors elicits anti-seizure activities
Q34953389Alteration of vascular reactivity in heart failure: role of phosphodiesterases 3 and 4.
Q36124226Alterations in perivascular innervation function in mesenteric arteries from offspring of diabetic rats.
Q42713715Alterations in pharmacological and behavioural responses in recombinant mouse line with an increased predisposition to catalepsy: role of the 5-HT1A receptor
Q36941265Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development
Q28384947Amyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's disease
Q42073494An analysis of glucocorticoid receptor-mediated gene expression in BEAS-2B human airway epithelial cells identifies distinct, ligand-directed, transcription profiles with implications for asthma therapeutics
Q35978063An atypical addition to the chemokine receptor nomenclature: IUPHAR Review 15.
Q34954063An in vivo role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A-4 3-O-phosphate.
Q37591810An inhaled dose of budesonide induces genes involved in transcription and signaling in the human airways: enhancement of anti- and proinflammatory effector genes.
Q109294882An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
Q38808034An update on PPAR activation by cannabinoids.
Q26863637Anaesthetics as cardioprotectants: translatability and mechanism
Q43105759Analgesic tolerance to morphine is regulated by PPARγ.
Q35693024Andrographolide derivative AL-1 improves insulin resistance through down-regulation of NF-κB signalling pathway
Q36211196Angiotensin II stimulation alters vasomotor response to adenosine in mouse mesenteric artery: role for A1 and A2B adenosine receptors
Q36036207Angiotensin-(1-7) administration benefits cardiac, renal and progenitor cell function in db/db mice
Q35484382Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation
Q35693008Annexin A1 mimetic peptide controls the inflammatory and fibrotic effects of silica particles in mice
Q38258912Annexin A2 complexes with S100 proteins: structure, function and pharmacological manipulation.
Q34619451Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice
Q28652289Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist
Q37084883Anti-oxidative effect of AST-120 on kidney injury after myocardial infarction
Q35693028Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy
Q36830107Antinociceptive effects of sinomenine in a rat model of postoperative pain
Q38802176Antioxidant effects of resveratrol in the cardiovascular system.
Q35631485Anxiolytic-like and anxiogenic-like effects of nicotine are regulated via diverse action at β2*nicotinic acetylcholine receptors
Q36903419Apelin-13 administration protects against ischaemia/reperfusion-mediated apoptosis through the FoxO1 pathway in high-fat diet-induced obesity.
Q99615032Applications of Genome-Wide Screening and Systems Biology Approaches in Drug Repositioning
Q27005619Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
Q36830145Aristolochic acid, a plant extract used in the treatment of pain and linked to Balkan endemic nephropathy, is a regulator of K2P channels
Q36342136Aspirin enhances protective effect of fish oil against thrombosis and injury-induced vascular remodelling
Q35865437Aspirin-induced histone acetylation in endothelial cells enhances synthesis of the secreted isoform of netrin-1 thus inhibiting monocyte vascular infiltration.
Q41295868Atenolol offers better protection than clonidine against cardiac injury in kainic acid-induced status epilepticus
Q42047360Auto-inhibition at a ligand-gated ion channel: a cross-talk between orthosteric and allosteric sites
Q38968834Autocrine secretion of 15d-PGJ2 mediates simvastatin-induced apoptotic burst in human metastatic melanoma cells
Q35484237Autophagy: an emerging therapeutic target in vascular diseases
Q37152985BCL11A Haploinsufficiency Causes an Intellectual Disability Syndrome and Dysregulates Transcription
Q46491819BJP is changing its requirements for scientific papers to increase transparency.
Q42594246BJP is linking its articles to the IUPHAR/BPS Guide to PHARMACOLOGY.
Q36903414BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice
Q34423181BU08073 a buprenorphine analogue with partial agonist activity at μ-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice
Q38825797Bcl-2 phosphorylation confers resistance on chronic lymphocytic leukaemia cells to the BH3 mimetics ABT-737, ABT-263 and ABT-199 by impeding direct binding
Q36830141Berberine improves mesenteric artery insulin sensitivity through up-regulating insulin receptor-mediated signalling in diabetic rats
Q36036224Betulinic acid exerts anti-hepatitis C virus activity via the suppression of NF-κB- and MAPK-ERK1/2-mediated COX-2 expression
Q38311702Beyond traditional pharmacology: new tools and approaches
Q34795759Biased allosteric modulation at the CaS receptor engendered by structurally diverse calcimimetics
Q30359656Biased ligand quantification in drug discovery: from theory to high throughput screening to identify new biased μ opioid receptor agonists
Q36342091Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery
Q38572850Bidirectional crosstalk via IL-6, PGE2 and PGD2 between murine myofibroblasts and alternatively activated macrophages enhances anti-inflammatory phenotype in both cells
Q35808594Bioinformatics-Aided Venomics
Q38532326Biophysics and Molecular Biology of Cardiac Ion Channels for the Safety Pharmacologist.
Q42149597Biphasic modulation by mGlu5 receptors of TRPV1-mediated intracellular calcium elevation in sensory neurons contributes to heat sensitivity.
Q42484273Blood-brain and retinal barriers show dissimilar ABC transporter impacts and concealed effect of P-glycoprotein on a novel verapamil influx carrier
Q34559598Buprenorphine signalling is compromised at the N40D polymorphism of the human μ opioid receptor in vitro
Q38987933CFTR potentiators partially restore channel function to A561E-CFTR, a cystic fibrosis mutant with a similar mechanism of dysfunction as F508del-CFTR
Q41997418CHEMGENIE: integration of chemogenomics data for applications in chemical biology
Q36546997COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common link.
Q42133705CREB, AP-1, ternary complex factors and MAP kinases connect transient receptor potential melastatin-3 (TRPM3) channel stimulation with increased c-Fos expression
Q35223948CXCR3 antagonist VUF10085 binds to an intrahelical site distinct from that of the broad spectrum antagonist TAK-779.
Q43101511Calcium affects OX1 orexin (hypocretin) receptor responses by modifying both orexin binding and the signal transduction machinery
Q35223942Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats
Q38848638Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
Q38572902Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPARγ and 5-HT1A receptors
Q38522769Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia
Q30392147Carbon nanomaterials combined with metal nanoparticles for theranostic applications
Q35204828Cardiac NO signalling in the metabolic syndrome
Q35286413Caveolins in cardioprotection - translatability and mechanisms
Q41817045Ceftriaxone attenuates acute cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens of the rat.
Q34953350Celastrol protects ischaemic myocardium through a heat shock response with up-regulation of haeme oxygenase-1.
Q36128810Cell type-specific transcriptomics of hypothalamic energy-sensing neuron responses to weight-loss
Q38188055Challenges for opioid receptor nomenclature: IUPHAR Review 9.
Q26773155Changes in Membrane Receptors and Ion Channels as Potential Biomarkers for Osteoarthritis
Q36744172Characterization of 12 GnRH peptide agonists - a kinetic perspective
Q42268714Characterization of zofenoprilat as an inducer of functional angiogenesis through increased H2 S availability.
Q38240702Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4.
Q36578335ChemProt-3.0: a global chemical biology diseases mapping
Q43145398Chinese innovation in cardiovascular drug discovery
Q35865464Chloride channels mediate sodium sulphide-induced relaxation in rat uteri
Q35223960Chronic exercise normalizes changes in Cav 1.2 and KCa 1.1 channels in mesenteric arteries from spontaneously hypertensive rats
Q36394967Chronic intermittent toluene inhalation in adolescent rats results in metabolic dysfunction with altered glucose homeostasis.
Q36211224Cinnamaldehyde inhibits inflammation and brain damage in a mouse model of permanent cerebral ischaemia
Q36342160Class A1 scavenger receptors in cardiovascular diseases
Q35111476Clinically used selective oestrogen receptor modulators increase LDL receptor activity in primary human lymphocytes.
Q36032797Cogena, a novel tool for co-expressed gene-set enrichment analysis, applied to drug repositioning and drug mode of action discovery
Q35223920Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice
Q41819842Combined treatment with bexarotene and rosuvastatin reduces angiotensin-II-induced abdominal aortic aneurysm in apoE(-/-) mice and angiogenesis.
Q36941251Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for allergic airways disease
Q38297306Combining citrulline with atorvastatin preserves glucose homeostasis in a murine model of diet-induced obesity
Q47964907Competitive association binding kinetic assays: a new tool to detect two different binding orientations of a ligand to its target protein under distinct conditions?
Q36546985Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo
Q37686141Compound 9a, a novel synthetic histone deacetylase inhibitor, protects against septic injury in mice by suppressing MAPK signalling
Q42030632Compound A, a selective glucocorticoid receptor agonist, inhibits immunoinflammatory diabetes, induced by multiple low doses of streptozotocin in mice.
Q94554231Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors
Q104151536Computational network biology: Data, models, and applications
Q41892145Conformational flexibility of the agonist binding jaw of the human P2X3 receptor is a prerequisite for channel opening
Q28081462Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes
Q36211201Continuous inhibition of 11β-hydroxysteroid dehydrogenase type I in adipose tissue leads to tachyphylaxis in humans and rats but not in mice
Q39674678Contractile function assessment by intraventricular balloon alters the ability of regional ischaemia to evoke ventricular fibrillation
Q42099574Contribution of adrenomedullin to the switch of G protein-coupled μ-opioid receptors from Gi to Gs in the spinal dorsal horn following chronic morphine exposure in rats
Q43105830Controlling the activation of the Bv8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals
Q34407185Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models
Q43419090Critical Cysteine Residues in Both the Calcium-Sensing Receptor and the Allosteric Activator AMG 416 Underlie the Mechanism of Action
Q36394992Crucial role of the orexin-B C-terminus in the induction of OX1 receptor-mediated apoptosis: analysis by alanine scanning, molecular modelling and site-directed mutagenesis.
Q36342164Cryptotanshinone, an orally bioactive herbal compound from Danshen, attenuates atherosclerosis in apolipoprotein E-deficient mice: role of lectin-like oxidized LDL receptor-1 (LOX-1).
Q64113855Current Advances in Studying Clinically Relevant Transporters of the Solute Carrier (SLC) Family by Connecting Computational Modeling and Data Science
Q28541617Cyclin-dependent kinase 5 is involved in the phosphorylation of gephyrin and clustering of GABAA receptors at inhibitory synapses of hippocampal neurons
Q36797373D-Penicillamine modulates hydrogen sulfide (H2S) pathway through selective inhibition of cystathionine-γ-lyase
Q36434749DGIdb 2.0: mining clinically relevant drug-gene interactions.
Q38915963DHEA modulates the effect of cortisol on RACK1 expression via interference with the splicing of the glucocorticoid receptor
Q27011914DNA demethylation and invasive cancer: implications for therapeutics
Q37084871Daily morphine administration increases impulsivity in rats responding under a 5-choice serial reaction time task
Q101476452Deciphering cell-cell interactions and communication from gene expression
Q37686138Decursin enhances TRAIL-induced apoptosis through oxidative stress mediated- endoplasmic reticulum stress signalling in non-small cell lung cancers
Q37084892Detecting moxifloxacin-induced QTc prolongation in thorough QT and early clinical phase studies using a highly automated ECG analysis approach
Q42559814Detection of the secondary, low-affinity β1 -adrenoceptor site in living cells using the fluorescent CGP 12177 derivative BODIPY-TMR-CGP.
Q39157622Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis
Q97552575Diabetic nephropathy produces alterations in the tissue expression profile of the orphan receptors GPR149, GPR153, GPR176, TAAR3, TAAR5 and TAAR9 in Wistar rats
Q36830115Diacylglycerol lipase β inhibition reverses nociceptive behaviour in mouse models of inflammatory and neuropathic pain.
Q38949654Diadenosine tetraphosphate induces tight junction disassembly thus increasing corneal epithelial permeability
Q36342144Dietary salt regulates epithelial sodium channels in rat endothelial cells: adaptation of vasculature to salt
Q36744208Differences in asthma study models and the effectiveness of β2 -adrenoceptor ligands: response to Lipworth et al.
Q34619471Different apoptotic effects of [Pt(O,O'-acac)(γ-acac)(DMS)] and cisplatin on normal and cancerous human epithelial breast cells in primary culture
Q35739137Different downstream signalling of CCK1 receptors regulates distinct functions of CCK in pancreatic beta cells
Q35111456Differential activation of human constitutive androstane receptor and its SV23 and SV24 splice variants by rilpivirine and etravirine
Q35223927Differential sensitivity of TREK-1, TREK-2 and TRAAK background potassium channels to the polycationic dye ruthenium red.
Q36797363Digoxin reduces atherosclerosis in apolipoprotein E-deficient mice
Q35911773Dimethyl fumarate induces necroptosis in colon cancer cells through GSH depletion/ROS increase/MAPKs activation pathway
Q36395003Dipeptidyl peptidase 4 promotes epithelial cell transformation and breast tumourigenesis via induction of PIN1 gene expression
Q35595863Discovery and pharmacological characterization of a novel potent inhibitor of diacylglycerol-sensitive TRPC cation channels
Q36599646Distinct and complementary roles for α and β isoenzymes of PKC in mediating vasoconstrictor responses to acutely elevated glucose
Q35538516Divergent effects of the 'biased' 5-HT1 A receptor agonists F15599 and F13714 in a novel object pattern separation task.
Q36893893Divergent modulation of Rho-kinase and Ca(2+) influx pathways by Src family kinases and focal adhesion kinase in airway smooth muscle.
Q47951444Docking and Virtual Screening in Drug Discovery
Q43101490Dopamine D1 and corticotrophin-releasing hormone type-2α receptors assemble into functionally interacting complexes in living cells
Q28256783Dopamine receptors - IUPHAR Review 13
Q35692993Dose-dependent biphasic leptin-induced proliferation is caused by non-specific IL-6/NF-κB pathway activation in human myometrial cells
Q41295260Down-regulation of IL-8 by high-dose vitamin D is specific to hyperinflammatory macrophages and involves mechanisms beyond up-regulation of DUSP1
Q36830132Drp-1, a potential therapeutic target for brain ischaemic stroke
Q42551182Drug effects on the CVS in conscious rats: separating cardiac output into heart rate and stroke volume using PKPD modelling
Q94960045Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
Q38568763Drug-target interaction prediction: databases, web servers and computational models
Q36507791Dynamics of Phosphoinositide-Dependent Signaling in Sympathetic Neurons.
Q38889914Dynasore enhances the formation of mitochondrial antiviral signalling aggregates and endocytosis-independent NF-κB activation
Q36036258Dysregulated post-transcriptional control of COX-2 gene expression in gestational diabetic endothelial cells
Q37085527Eact, a small molecule activator of TMEM16A, activates TRPV1 and elicits pain- and itch-related behaviours
Q40625919Early treatment with atorvastatin exerts parenchymal and vascular protective effects in experimental cerebral ischaemia
Q42552831Effect of erythropoietin on hepatic cytochrome P450 expression and function in an adenine-fed rat model of chronic kidney disease
Q34939900Effect of naltrexone on neuropathic pain in mice locally transfected with the mutant μ-opioid receptor gene in spinal cord
Q42412797Effect of polyphenolic phytochemicals on ectopic oxidative phosphorylation in rod outer segments of bovine retina
Q35573896Effect of tyrphostin AG879 on Kv 4.2 and Kv 4.3 potassium channels
Q35846206Effective suppression of pro-inflammatory molecules by DHCA via IKK-NF-κB pathway, in vitro and in vivo.
Q38694069Effects of P2Y12 receptor antagonists beyond platelet inhibition--comparison of ticagrelor with thienopyridines
Q43019107Effects of acute and chronic sunitinib treatment on cardiac function and calcium/calmodulin-dependent protein kinase II.
Q34914328Effects of caffeine on circadian phase, amplitude and period evaluated in cells in vitro and peripheral organs in vivo in PER2::LUCIFERASE mice
Q42114497Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling
Q36903400Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes.
Q35895873Effects of new-generation inhibitors of the calcium-activated chloride channel anoctamin 1 on slow waves in the gastrointestinal tract
Q41432075Effects of receptor tyrosine kinase inhibitors on VEGF165 a- and VEGF165 b-stimulated gene transcription in HEK-293 cells expressing human VEGFR2.
Q37084868Effects of the imidazoline I2 receptor agonist 2-BFI on the development of tolerance to and behavioural/physical dependence on morphine in rats
Q35538521Effects of the novel BK (KCa 1.1) channel opener GoSlo-SR-5-130 are dependent on the presence of BKβ subunits
Q36124232Eicosapentaenoic acid prevents TCDD-induced oxidative stress and inflammatory response by modulating MAP kinases and redox-sensitive transcription factors
Q36342111Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases
Q34559604Emodin inhibits tonic tension through suppressing PKCδ-mediated inhibition of myosin phosphatase in rat isolated thoracic aorta
Q35682184Enantioselective inhibition of d-serine transport by (S)-ketamine
Q34953319Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey
Q42107964Endocannabinoids modulate human blood-brain barrier permeability in vitro
Q38235155Endothelial atypical cannabinoid receptor: do we have enough evidence?
Q26767156Endothelin
Q36016411Endothelin ETA receptor/lipid peroxides/COX-2/TGF-β1 signalling underlies aggravated nephrotoxicity caused by cyclosporine plus indomethacin in rats
Q43101498Endothelin-1 contributes to endothelial dysfunction and enhanced vasoconstriction through augmented superoxide production in penile arteries from insulin-resistant obese rats: role of ET(A) and ET(B) receptors.
Q37084544Endothelin-1 contributes to the progression of renal injury in sickle cell disease via reactive oxygen species
Q40559309Endothelin-1 shifts the mediator of bradykinin-induced relaxation from NO to H2 O2 in resistance arteries from patients with cardiovascular disease
Q37686147Endothelin-1 suppresses insulin-stimulated Akt phosphorylation and glucose uptake via GPCR kinase 2 in skeletal muscle cells
Q41891837Endothelin-converting enzyme 2 differentially regulates opioid receptor activity
Q28246158Endothelin@25 - new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12
Q35286438Enhanced GABAergic synaptic transmission at VLPAG neurons and potent modulation by oxycodone in a bone cancer pain model
Q36506903Enhanced serelaxin signalling in co-cultures of human primary endothelial and smooth muscle cells
Q38233723Epigenetic pathway targets for the treatment of disease: accelerating progress in the development of pharmacological tools: IUPHAR Review 11.
Q35631463Epigenetics in the perioperative period
Q35865417Eugenol dilates mesenteric arteries and reduces systemic BP by activating endothelial cell TRPV4 channels
Q28083604Evaluation of drug-induced QT interval prolongation in animal and human studies: a literature review of concordance
Q34954104Evaluation of peripheral versus central effects of GABA(B) receptor activation using a novel, positive allosteric modulator of the GABA(B) receptor ADX71943, a pharmacological tool compound with a fully peripheral activity profile
Q35223907Evidence for annexin A6-dependent plasma membrane remodelling of lipid domains.
Q47893147Evidence-Based Precision Oncology with the Cancer Targetome.
Q35204841Exogenous administration of thiosulfate, a donor of hydrogen sulfide, attenuates angiotensin II-induced hypertensive heart disease in rats
Q26801615Expanding opportunities for mining bioactive chemistry from patents
Q89875049Exploring Integrative Analysis Using the BioMedical Evidence Graph
Q27021649Extending the translational potential of targeting NO/cGMP-regulated pathways in the CVS
Q35286339Extracellular signalling molecules in the ischaemic/reperfused heart - druggable and translatable for cardioprotection?
Q35111461FM19G11 reverses endothelial dysfunction in rat and human arteries through stimulation of the PI3K/Akt/eNOS pathway, independently of mTOR/HIF-1α activation.
Q36599618Fasting protects against the side effects of irinotecan treatment but does not affect anti-tumour activity in mice
Q37686153Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR-α/sirtuin 1/PGC-1α pathway
Q28649345Finding small molecules for the 'next Ebola'
Q27021274Fine-tuning somatostatin receptor signalling by agonist-selective phosphorylation and dephosphorylation: IUPHAR Review 5
Q37446861Fluorescence- and bioluminescence-based approaches to study GPCR ligand binding.
Q34435307Fluoxetine elevates allopregnanolone in female rat brain but inhibits a steroid microsomal dehydrogenase rather than activating an aldo-keto reductase.
Q42926933From mouse to man: predicting biased effects of beta-blockers in asthma.
Q37686113Functional, electrophysiological and molecular docking analysis of the modulation of Cav 1.2 channels in rat vascular myocytes by murrayafoline A.
Q28087460Future technology insight: mass spectrometry imaging as a tool in drug research and development
Q28081099G Protein-Coupled Receptor (GPCR) Expression in Native Cells: "Novel" endoGPCRs as Physiologic Regulators and Therapeutic Targets
Q35538506GPCR dimerization in brainstem nuclei contributes to the development of hypertension.
Q39959829GPCR-mediated EGF receptor transactivation regulates TRPV4 action in the vasculature
Q36398022GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis.
Q27005640Gaddum Memorial Lecture 2014: receptors as an evolving concept: from switches to biased microprocessors
Q36599642Galanin inhibits GLP-1 and GIP secretion via the GAL1 receptor in enteroendocrine L and K cells
Q37084887Gender-related differential effect of tachykinin NK2 receptor-mediated visceral hyperalgesia in guinea pig colon
Q28087587Generic GPCR residue numbers - aligning topology maps while minding the gaps
Q36036232Genetic deficit of KCa 3.1 channels protects against pulmonary circulatory collapse induced by TRPV4 channel activation.
Q40834847Genetic predisposition to albuminuria is associated with increased arterial stiffness: role of elastin
Q37686132Genipin alleviates sepsis-induced liver injury by restoring autophagy
Q36342172Genistein alleviates pressure overload-induced cardiac dysfunction and interstitial fibrosis in mice
Q39090278Genomic variant annotation workflow for clinical applications
Q38921881Glial cell line-derived neurotrophic factor-mediated enhancement of noradrenergic descending inhibition in the locus coeruleus exerts prolonged analgesia in neuropathic pain
Q28067465Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes
Q35538527Glucose modulation induces reactive oxygen species and increases P-glycoprotein-mediated multidrug resistance to chemotherapeutics.
Q38974021Glutathione administration reduces mitochondrial damage and shifts cell death from necrosis to apoptosis in ageing diabetic mice hearts during exercise
Q35484483Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice
Q31053398Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic risk
Q34953430Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling
Q36744223High avidity chimeric monoclonal antibodies against the extracellular domains of human aquaporin-4 competing with the neuromyelitis optica autoantibody, NMO-IgG.
Q36744177High glucose-induced changes in hyaloid-retinal vessels during early ocular development of zebrafish: a short-term animal model of diabetic retinopathy
Q35223938High-affinity σ1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis.
Q36546975High-density lipoprotein inhibits human M1 macrophage polarization through redistribution of caveolin-1.
Q37005127High-fat diet-induced metabolic disorders impairs 5-HT function and anxiety-like behavior in mice
Q40160363Hippocampal 5-HT7 receptors signal phosphorylation of the GluA1 subunit to facilitate AMPA receptor mediated-neurotransmission in vitro and in vivo
Q38264340Histamine H₄ receptors in the gastrointestinal tract.
Q36744218Homoharringtonine binds to and increases myosin-9 in myeloid leukaemia
Q37084539Honokiol sensitizes breast cancer cells to TNF-α induction of apoptosis by inhibiting Nur77 expression
Q92219065How to Develop a Drug Target Ontology: KNowledge Acquisition and Representation Methodology (KNARM)
Q35693003HuR mediates the synergistic effects of angiotensin II and IL-1β on vascular COX-2 expression and cell migration
Q42606979Human induced pluripotent stem cell-derived versus adult cardiomyocytes: an in silico electrophysiological study on effects of ionic current block.
Q35484400Human organic anion transporting polypeptide 1A2 (OATP1A2) mediates cellular uptake of all-trans-retinol in human retinal pigmented epithelial cells
Q35846184Hunting for the function of orphan GPCRs - beyond the search for the endogenous ligand.
Q42317689Hydrogen peroxide activates store-operated Ca(2+) entry in coronary arteries.
Q34795751Hydrogen peroxide stimulation of CFTR reveals an Epac-mediated, soluble AC-dependent cAMP amplification pathway common to GPCR signalling
Q38236845Hydrogen sulfide: physiological properties and therapeutic potential in ischaemia.
Q35314338Hydrogen sulphide protects against NSAID-enteropathy through modulation of bile and the microbiota.
Q38564991Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management
Q38808680Hypoglycemia unawareness prevention: Targeting glucagon production
Q34914125IL-1β and IL-18: inflammatory markers or mediators of hypertension?
Q35978086IL-1β reduces tonic contraction of mesenteric lymphatic muscle cells, with the involvement of cycloxygenase-2 and prostaglandin E2.
Q35865421Identification and optimization of 2-aminobenzimidazole derivatives as novel inhibitors of TRPC4 and TRPC5 channels
Q37084901Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics.
Q40954666Identification of Histamine H3 Receptor Ligands Using a New Crystal Structure Fragment-based Method.
Q38833147Identification of N-arachidonoyl dopamine as a highly biased ligand at cannabinoid CB1 receptors
Q36744202Identification of a resveratrol tetramer as a potent inhibitor of hepatitis C virus helicase
Q39909994Identification of a selective glucocorticoid receptor modulator that prevents both diet-induced obesity and inflammation
Q34402836Identification of an old antibiotic clofoctol as a novel activator of unfolded protein response pathways and an inhibitor of prostate cancer
Q36016417Identification of matrine as a promising novel drug for hepatic steatosis and glucose intolerance with HSP72 as an upstream target
Q34447665Identification of muscarinic receptor subtypes involved in catecholamine secretion in adrenal medullary chromaffin cells by genetic deletion
Q34669726Identification of novel insulin mimetic drugs by quantitative total internal reflection fluorescence (TIRF) microscopy.
Q36830137Identification of sirtuin 1 as a promising therapeutic target for hypertrophic scars
Q37183342Identification of the putative binding pocket of valerenic acid on GABAA receptors using docking studies and site-directed mutagenesis.
Q38978556Identifying bias in CCR1 antagonists using radiolabelled binding, receptor internalization, β-arrestin translocation and chemotaxis assays
Q38720041Identifying ligands at orphan GPCRs: current status using structure-based approaches
Q35911759Imidazole-based alkaloid derivative LCB54-0009 suppresses ocular angiogenesis and lymphangiogenesis in models of experimental retinopathy and corneal neovascularization.
Q36547012Immunoinflammatory diseases of the central nervous system - the tale of two cytokines
Q36797398Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18.
Q90295510In Silico Target Prediction for Small Molecules
Q47168067In silico prediction of chemical mechanism of action via an improved network-based inference method
Q34571432In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives.
Q35538532In vitro and in vivo regulation of synaptogenesis by the novel antidepressant spadin
Q34914312In vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1.
Q34953409In vivo properties of KNT-127, a novel δ opioid receptor agonist: receptor internalization, antihyperalgesia and antidepressant effects in mice
Q35039228Indoline-3-propionate and 3-aminopropyl carbamates reduce lung injury and pro-inflammatory cytokines induced in mice by LPS
Q37686319Induction of endothelium-dependent constriction of mesenteric arteries in endotoxemic hypotensive shock.
Q38263512Induction of the inflammatory regulator A20 by gibberellic acid in airway epithelial cells
Q36546979Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt-induced hypertension in mice.
Q36546990Inflammation in acute CNS injury: a focus on the role of substance P
Q42552830Inflammation: maladies, models, mechanisms and molecules
Q35693020Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation.
Q41861087Inhibition of L-carnitine biosynthesis and transport by methyl-γ-butyrobetaine decreases fatty acid oxidation and protects against myocardial infarction
Q35911749Inhibition of breast cancer progression by a novel histone deacetylase inhibitor, LW479, by down-regulating EGFR expression.
Q36941262Inhibition of fatty acid synthase is protective in pulmonary hypertension
Q34994542Inhibition of monoacylglycerol lipase reduces nicotine withdrawal
Q40920822Inhibition of prostate smooth muscle contraction and prostate stromal cell growth by the inhibitors of Rac, NSC23766 and EHT1864.
Q37686101Inhibition of the regulator of G protein signalling RGS4 in the spinal cord decreases neuropathic hyperalgesia and restores cannabinoid CB1 receptor signalling
Q56980193Insights into Transporter Classifications: an Outline of Transporters as Drug Targets
Q41635414Integrating the GPCR transactivation-dependent and biased signalling paradigms in the context of PAR1 signalling.
Q37686098Integration of reward signalling and appetite regulating peptide systems in the control of food-cue responses.
Q58104031Integrative Data Mining, Scaffold Analysis, and Sequential Binary Classification Models for Exploring Ligand Profiles of Hepatic Organic Anion Transporting Polypeptides (OATPs)
Q36016439Inter-study variability of preclinical in vivo safety studies and translational exposure-QTc relationships--a PKPD meta-analysis.
Q35111472Interaction between positive allosteric modulators and trapping blockers of the NMDA receptor channel.
Q41912702Interplay between the kinin B1 receptor and inducible nitric oxide synthase in insulin resistance
Q36941272Intersubunit interactions at putative sites of ethanol action in the M3 and M4 domains of the NMDA receptor GluN1 and GluN2B subunits
Q36830128Intranasal exposure to monoclonal antibody Fab fragments to Japanese cedar pollen Cry j1 suppresses Japanese cedar pollen-induced allergic rhinitis
Q36599633Involvement of Rac1 signalling pathway in the development and maintenance of acute inflammatory pain induced by bee venom injection
Q35631488Involvement of neuronal TGF-β activated kinase 1 in the development of tolerance to morphine-induced antinociception in rat spinal cord
Q37084878Involvement of the orexin/hypocretin system in the pharmacological effects induced by Δ(9) -tetrahydrocannabinol
Q36599656Involvement of transglutaminase 2 and voltage-gated potassium channels in cystamine vasodilatation in rat mesenteric small arteries.
Q92756951Ion Channel Expression in Human Melanoma Samples: In Silico Identification and Experimental Validation of Molecular Targets
Q34994519Ionic mechanisms underlying the negative chronotropic action of propofol on sinoatrial node automaticity in guinea pig heart
Q40046136Is systems pharmacology ready to impact upon therapy development? A study on the cholesterol biosynthesis pathway
Q27000466Ischaemic conditioning: pitfalls on the path to clinical translation
Q35692999Kaempferol enhances endothelium-dependent relaxation in the porcine coronary artery through activation of large-conductance Ca(2+) -activated K(+) channels
Q34480719Ketamine and phencyclidine: the good, the bad and the unexpected
Q40920574Ketamine coadministration attenuates morphine tolerance and leads to increased brain concentrations of both drugs in the rat.
Q36533102Knockdown of the small conductance Ca(2+) -activated K(+) channels is potently cytotoxic in breast cancer cell lines
Q39116722Kv 11.1 (hERG)-induced cardiotoxicity: a molecular insight from a binding kinetics study of prototypical Kv 11.1 (hERG) inhibitors.
Q39960011LPS exacerbates functional and inflammatory responses to ovalbumin and decreases sensitivity to inhaled fluticasone propionate in a guinea pig model of asthma
Q42173694Lack of weight gain after angiotensin AT1 receptor blockade in diet-induced obesity is partly mediated by an angiotensin-(1-7)/Mas-dependent pathway
Q40720078Large-Scale Combinatorial Deorphanization of Platynereis Neuropeptide GPCRs
Q50936162Large-scale identification of potential drug targets based on the topological features of human protein-protein interaction network.
Q57434536Ligand-Mediated Toxicology: Characterization and Translational Prospects
Q34954084Lipoxin A4 suppresses the development of endometriosis in an ALX receptor-dependent manner via the p38 MAPK pathway
Q35039240Localization of sunitinib, its metabolites and its target receptors in tumour-bearing mice: a MALDI-MS imaging study
Q27022641Localization of α-adrenoceptors: JR Vane Medal Lecture
Q35978075Long-lasting partnership between insulin resistance and endothelial dysfunction: role of metabolic memory.
Q36744182Loss of 5-lipoxygenase activity protects mice against paracetamol-induced liver toxicity
Q38825816Low free drug concentration prevents inhibition of F508del CFTR functional expression by the potentiator VX-770 (ivacaftor).
Q40849897Luminal 5-HT stimulates colonic bicarbonate secretion in rats
Q34025135Lysophospholipid receptor nomenclature review: IUPHAR Review 8.
Q38863938MD-2 as the target of a novel small molecule, L6H21, in the attenuation of LPS-induced inflammatory response and sepsis
Q42109896MLN4924 sensitizes monocytes and maturing dendritic cells for TNF-dependent and -independent necroptosis
Q35484424MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway
Q92724567Machine learning approaches and databases for prediction of drug-target interaction: a survey paper
Q36394984Macrolides increase the expression of 11β-hydroxysteroid dehydrogenase 1 in human sinonasal epithelium, contributing to glucocorticoid activation in sinonasal mucosa
Q37686310Madecassoside ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting the generation of hepatocyte growth factor via PPAR-γ in colon
Q27943500Many InChIs and quite some feat
Q37685010Mapping the function of neuronal ion channels in model and experiment
Q38809010Mass spectrometric analysis of synaptosomal membrane preparations for the determination of brain receptors, transporters and channels
Q35204865Measurement of NO in biological samples
Q28601949Mechanism of allosteric activation of TMEM16A/ANO1 channels by a commonly used chloride channel blocker
Q36016433Mechanism of inhibition of mouse Slo3 (KCa 5.1) potassium channels by quinine, quinidine and barium
Q37686121Mechanisms by which the thiazolidinedione troglitazone protects against sucrose-induced hepatic fat accumulation and hyperinsulinaemia
Q34795689Mechanisms underlying the cytotoxicity of a novel quinazolinedione-based redox modulator, QD232, in pancreatic cancer cells
Q37686103Medial prefrontal cortex TRPV1 channels modulate the baroreflex cardiac activity in rats
Q42107527Melatonin-sulforaphane hybrid ITH12674 induces neuroprotection in oxidative stress conditions by a 'drug-prodrug' mechanism of action
Q36506877Meningeal blood flow is controlled by H2 S-NO crosstalk activating a HNO-TRPA1-CGRP signalling pathway
Q35865424Meta-chlorophenylpiperazine enhances leptin sensitivity in diet-induced obese mice.
Q30885784Metabolic Profiling and Phenotyping of Central Nervous System Diseases: Metabolites Bring Insights into Brain Dysfunctions
Q34953372Metabolic characteristics of 13-cis-retinoic acid (isotretinoin) and anti-tumour activity of the 13-cis-retinoic acid metabolite 4-oxo-13-cis-retinoic acid in neuroblastoma
Q38567309Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus bias
Q37686108Mevastatin ameliorates sphingosine 1-phosphate-induced COX-2/PGE2-dependent cell migration via FoxO1 and CREB phosphorylation and translocation
Q34402820Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858F NaV 1.7 sodium channels.
Q38692790Microglia antioxidant systems and redox signalling
Q36547001Microglial M1/M2 polarization and metabolic states
Q36546971Microglial activation and progressive brain changes in schizophrenia
Q36506889Mirabegron relaxes urethral smooth muscle by a dual mechanism involving β3 -adrenoceptor activation and α1 -adrenoceptor blockade
Q35223924Mitochondrial (dys)function - a factor underlying the variability of efavirenz-induced hepatotoxicity?
Q41056910Model-based prediction of the acute and long-term safety profile of naproxen in rats
Q36797402Molecular and functional characterization of Kv 7 channels in penile arteries and corpus cavernosum of healthy and metabolic syndrome rats.
Q42088341Molecular basis of agonist docking in a human GPR103 homology model by site-directed mutagenesis and structure-activity relationship studies
Q42554178Molecular determinants for the high constitutive activity of the human histamine H4 receptor: functional studies on orthologues and mutants
Q39062474Molecular determinants of positive allosteric modulation of the human metabotropic glutamate receptor 2.
Q36211191Molecular dynamics and functional studies define a hot spot of crystal contacts essential for PcTx1 inhibition of acid-sensing ion channel 1a.
Q42221343Molecular mechanism of allosteric modulation at GPCRs: insight from a binding kinetics study at the human A1 adenosine receptor
Q42700069Molecular mechanism of positive allosteric modulation of the metabotropic glutamate receptor 2 by JNJ-46281222.
Q35039217Molecular mechanisms governing different pharmacokinetics of ginsenosides and potential for ginsenoside-perpetrated herb-drug interactions on OATP1B3.
Q38597820Molecular switches under TGFβ signalling during progression from cardiac hypertrophy to heart failure
Q34914164Molecular targets of the multifunctional iron-chelating drug, M30, in the brains of mouse models of type 2 diabetes mellitus
Q36599623Monoclonal antibodies: the new magic bullets for allergy: IUPHAR Review 17.
Q43019372Monoglyceride lipase deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity
Q34559591Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine--a quantitative EEG study in rats
Q35187070Multiple roles of the PGE2 -EP receptor signal in vascular permeability
Q36599662N-terminally and C-terminally truncated forms of glucose-dependent insulinotropic polypeptide are high-affinity competitive antagonists of the human GIP receptor
Q38691764NADPH oxidases in oxidant production by microglia: activating receptors, pharmacology and association with disease
Q40920604NVP-QBE170: an inhaled blocker of the epithelial sodium channel with a reduced potential to induce hyperkalaemia
Q35851832NVP-TAE684 reverses multidrug resistance (MDR) in human osteosarcoma by inhibiting P-glycoprotein (PGP1) function.
Q40324920Natural and synthetic flavonoid modulation of TRPC5 channels
Q88785856Network-Based Disease Module Discovery by a Novel Seed Connector Algorithm with Pathobiological Implications
Q88973776Network-based Drug Repurposing for Human Coronavirus
Q92872703Network-based Prediction of Drug-Target Interactions using an Arbitrary-Order Proximity Embedded Deep Forest
Q55643995Network-based approach to prediction and population-based validation of in silico drug repurposing.
Q90482543Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Q64099168Network-based prediction of drug combinations
Q36744227Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis
Q36394976Neurokinin 1 receptor blockade in the medial amygdala attenuates alcohol drinking in rats with innate anxiety but not in Wistar rats.
Q37005143Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease
Q34914245Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders
Q35978159Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors.
Q38263507Neutrophil elastase induces inflammation and pain in mouse knee joints via activation of proteinase-activated receptor-2.
Q51210141New N- and O-arylpiperazinylalkyl pyrimidines and 2-methylquinazolines derivatives as 5-HT7 and 5-HT1A receptor ligands: Synthesis, structure-activity relationships, and molecular modeling studies.
Q38779697New aspects of p66Shc in ischaemia reperfusion injury and other cardiovascular diseases
Q35978145New selective inhibitors of calcium-activated chloride channels - T16A(inh) -A01, CaCC(inh) -A01 and MONNA - what do they inhibit?
Q36903409New use for an old drug: COX-independent anti-inflammatory effects of sulindac in models of cystic fibrosis.
Q39674355Nicergoline inhibits human platelet Ca(2+) signalling through triggering a microtubule-dependent reorganization of the platelet ultrastructure
Q91826855NicheNet: modeling intercellular communication by linking ligands to target genes
Q34572211Nicotinic acetylcholine receptors control acetylcholine and noradrenaline release in the rodent habenulo-interpeduncular complex
Q38264366Noble gases as cardioprotectants - translatability and mechanism
Q37084897Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthma
Q35111445Novel Nrf2 activators from microbial transformation products inhibit blood-retinal barrier permeability in rabbits.
Q36941258Novel application assigned to toluquinol: inhibition of lymphangiogenesis by interfering with VEGF-C/VEGFR-3 signalling pathway.
Q34953338Novel coumarin modified GLP-1 derivatives with enhanced plasma stability and prolonged in vivo glucose-lowering ability
Q35484363Novel immunosuppressive agent caerulomycin A exerts its effect by depleting cellular iron content
Q36342131Novel strategies and underlying protective mechanisms of modulation of vagal activity in cardiovascular diseases
Q36342140Nuciferine relaxes rat mesenteric arteries through endothelium-dependent and -independent mechanisms.
Q36342177Oestrogen inhibits BMP4-induced BMP4 expression in cardiomyocytes: a potential mechanism of oestrogen-mediated protection against cardiac hypertrophy
Q38710840On the different experimental manifestations of two-state 'induced-fit' binding of drugs to their cellular targets
Q35286353Opioid receptors and cardioprotection - 'opioidergic conditioning' of the heart
Q38631744Optical probes based on G protein-coupled receptors - added work or added value?
Q34559586Orexin A activates hypoglossal motoneurons and enhances genioglossus muscle activity in rats.
Q35471045Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers
Q38960964Oxidized LDL-induced angiogenesis involves sphingosine 1-phosphate: prevention by anti-S1P antibody
Q34518822Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activity
Q92676934P2X4 receptors, immunity, and sepsis
Q34402844PAR1-dependent COX-2/PGE2 production contributes to cell proliferation via EP2 receptors in primary human cardiomyocytes
Q36016406PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis
Q100733548PIMD: An Integrative Approach for Drug Repositioning Using Multiple Characterization Fusion
Q43105838PKC inhibition results in a Kv 1.5 + Kv β1.3 pharmacology closer to Kv 1.5 channels.
Q36016445PKCε phosphorylates α4β2 nicotinic ACh receptors and promotes recovery from desensitization
Q35865449PKPD modelling to predict altered disposition of 1α,25-dihydroxyvitamin D3 in mice due to dose-dependent regulation of CYP27B1 on synthesis and CYP24A1 on degradation.
Q37686110PPARγ agonists regulate bidirectional transport of amyloid-β across the blood-brain barrier and hippocampus plasticity in db/db mice
Q34914220PPemd26, an anthraquinone derivative, suppresses angiogenesis via inhibiting VEGFR2 signalling
Q34571380Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels
Q34795735Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent
Q36941269Pancreatic polypeptide and its central Y4 receptors are essential for cued fear extinction and permanent suppression of fear
Q35978108Pelitinib (EKB-569) targets the up-regulation of ABCB1 and ABCG2 induced by hyperthermia to eradicate lung cancer
Q35978127Pharmacological actions of nobiletin in the modulation of platelet function.
Q38909233Pharmacological and electrophysiological characterization of AZSMO-23, an activator of the hERG K(+) channel
Q34402775Pharmacological bronchodilation is partially mediated by reduced airway wall stiffness
Q36797357Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivo
Q36599638Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4
Q35911768Pharmacological inhibition of caspase-8 limits lung tumour outgrowth.
Q34407191Pharmacological manipulations in animal models of anorexia and binge eating in relation to humans.
Q38915494Pharmacological methyl group donors block skeletal metastasis in vitro and in vivo.
Q35693011Pharmacological modulation of autophagy to protect cardiomyocytes according to the time windows of ischaemia/reperfusion
Q34466872Pharmacological profile of novel psychoactive benzofurans
Q35223930Pharmacological profile of opicapone, a third-generation nitrocatechol catechol-O-methyl transferase inhibitor, in the rat.
Q34402759Pharmacological regulators of autophagy and their link with modulators of lupus disease
Q34994550Pharmacological targeting of GSK3β confers protection against podocytopathy and proteinuria by desensitizing mitochondrial permeability transition
Q38218546Pharmacological tools for hydrogen sulphide research: a brief, introductory guide for beginners
Q39176672Pharmacologically distinct phenotypes of α1B -adrenoceptors: variation in binding and functional affinities for antagonists.
Q36211219Pharmacophore-based discovery of inhibitors of a novel drug/proton antiporter in human brain endothelial hCMEC/D3 cell line
Q28084793Phosphodiesterase 4D: an enzyme to remember
Q35039202Physiological, pharmacological and toxicological considerations of drug-induced structural cardiac injury
Q40946825Platelet secretion of CXCL4 is Rac1-dependent and regulates neutrophil infiltration and tissue damage in septic lung damage
Q42205768Pleiotropic, heart rate-independent cardioprotection by ivabradine.
Q36797368PnPP-19, a spider toxin peptide, induces peripheral antinociception through opioid and cannabinoid receptors and inhibition of neutral endopeptidase
Q36599652Possible pharmacotherapy for nifedipine-induced gingival overgrowth: 18α-glycyrrhetinic acid inhibits human gingival fibroblast growth
Q38787139Possible role for anisodamine in organophosphate poisoning
Q27021021Postconditioning signalling in the heart: mechanisms and translatability
Q38752093Posttranscriptional regulation of FOXO expression: microRNAs and beyond
Q34472557Potent anti-inflammatory effects of the narrow spectrum kinase inhibitor RV1088 on rheumatoid arthritis synovial membrane cells
Q34795742Preclinical development of AMG 139, a human antibody specifically targeting IL-23
Q36094756Prediction of compound-target interactions of natural products using large-scale drug and protein information.
Q90456344Prediction of the allergic mechanism of haptens via a reaction-substructure-compound-target-pathway network system
Q36351777Predictive Modeling of Drug Treatment in the Area of Personalized Medicine
Q28077186Present and future pharmacotherapeutic agents in heart failure: an evolving paradigm
Q35039222Presynaptic adenosine A2A receptors dampen cannabinoid CB1 receptor-mediated inhibition of corticostriatal glutamatergic transmission
Q36797353Presynaptic, release-regulating mGlu2 -preferring and mGlu3 -preferring autoreceptors in CNS: pharmacological profiles and functional roles in demyelinating disease
Q34994537Preventing leptin resistance by blocking angiotensin II AT1 receptors in diet-induced obese rats
Q35978121Prevention of the degeneration of human dopaminergic neurons in an astrocyte co-culture system allowing endogenous drug metabolism
Q36903395Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats
Q36394997Pro-cognitive activity in rats of 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptor
Q36547016Progressive inflammation-mediated neurodegeneration after traumatic brain or spinal cord injury
Q35978103Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation-induced anaemia in rats
Q36394973Propranolol decreases retention of fear memory by modulating the stability of surface glutamate receptor GluA1 subunits in the lateral amygdala
Q34494513Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?
Q37686116Prostaglandin E2 inhibits neutrophil extracellular trap formation through production of cyclic AMP.
Q38722647Protease-activated receptor 4: from structure to function and back again
Q36797390Protection against cardiac hypertrophy by geniposide involves the GLP-1 receptor / AMPKα signalling pathway
Q28606782Protective effect of 23-hydroxybetulinic acid on doxorubicin-induced cardiotoxicity: a correlation with the inhibition of carbonyl reductase-mediated metabolism
Q43200667Protective effect of exogenous nitrite in postoperative ileus
Q38835918Protective effect of the multitarget compound DPH-4 on human SSAO/VAP-1-expressing hCMEC/D3 cells under oxygen-glucose deprivation conditions: an in vitro experimental model of cerebral ischaemia.
Q43114230Protective effects of n-6 fatty acids-enriched diet on intestinal ischaemia/reperfusion injury involve lipoxin A4 and its receptor.
Q34795775Protective role of olesoxime against wild-type α-synuclein-induced toxicity in human neuronally differentiated SHSY-5Y cells
Q28647166Proteinases, their receptors and inflammatory signalling: the Oxford South Parks Road connection
Q43101504Protons modulate perivascular axo-axonal neurotransmission in the rat mesenteric artery
Q34402767Purinergic neuromuscular transmission in the gastrointestinal tract; functional basis for future clinical and pharmacological studies
Q38972404Putative binding sites for arachidonic acid on the human cardiac Kv 1.5 channel
Q47407582Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches.
Q35538485Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues
Q34402813Quercetin attenuates doxorubicin cardiotoxicity by modulating Bmi-1 expression.
Q39674704Quetiapine and its metabolite norquetiapine: translation from in vitro pharmacology to in vivo efficacy in rodent models.
Q35978155Quinazoline-4-piperidine sulfamides are specific inhibitors of human NPP1 and prevent pathological mineralization of valve interstitial cells
Q89674046Quorum Regulation via Nested Antagonistic Feedback Circuits Mediated by the Receptors CD28 and CTLA-4 Confers Robustness to T Cell Population Dynamics
Q38693962ROS in gastrointestinal inflammation: Rescue Or Sabotage?
Q35911741Rapamycin impairs HPD-induced beneficial effects on glucose homeostasis
Q35865412Rapid ventricular pacing-induced postconditioning attenuates reperfusion injury: effects on peroxynitrite, RISK and SAFE pathways
Q34439244Rare platelet GPCR variants: what can we learn?
Q35978080Receptors involved in the modulation of guinea pig urinary bladder motility by prostaglandin D2.
Q35286322Redox signalling and cardioprotection: translatability and mechanism
Q39959986Regulation of μ and δ opioid receptor functions: involvement of cyclin-dependent kinase 5.
Q36342101Regulator of G-protein signalling 5 protects against atherosclerosis in apolipoprotein E-deficient mice
Q38802490Relaxin and insulin-like peptide 3 in the musculoskeletal system: from bench to bedside
Q30384507Relief learning is dependent on NMDA receptor activation in the nucleus accumbens
Q38249023Remote conditioning the heart overview: translatability and mechanism
Q37681996Renal effects of chronic pharmacological manipulation of CB2 receptors in rats with diet-induced obesity
Q34939968Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey.
Q38829760Resveratrol exerts a biphasic effect on apolipoprotein M.
Q56992819Review and comparative assessment of similarity-based methods for prediction of drug–protein interactions in the druggable human proteome
Q34424009Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10.
Q36211185Role for engagement of β-arrestin2 by the transactivated EGFR in agonist-specific regulation of δ receptor activation of ERK1/2.
Q36797387Role of COX-2-derived PGE2 on vascular stiffness and function in hypertension
Q36796418Role of EP2 and EP4 receptors in airway microvascular leak induced by prostaglandin E2.
Q35846201Role of aldehyde dehydrogenase in hypoxic vasodilator effects of nitrite in rats and humans
Q37108442Role of endothelial TRPV4 channels in vascular actions of the endocannabinoid, 2-arachidonoylglycerol.
Q26830560Role of the MPTP in conditioning the heart - translatability and mechanism
Q37085532Role of the endocannabinoid system in diabetes and diabetic complications
Q34954019Roscovitine is a proteostasis regulator that corrects the trafficking defect of F508del-CFTR by a CDK-independent mechanism
Q28250152Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptors
Q38223040S-nitrosation and neuronal plasticity.
Q42248921S1P-induced airway smooth muscle hyperresponsiveness and lung inflammation in vivo: molecular and cellular mechanisms
Q36830103Safety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects
Q35846190Salidroside ameliorates insulin resistance through activation of a mitochondria-associated AMPK/PI3K/Akt/GSK3β pathway.
Q37686096Salsalate attenuates diet induced non-alcoholic steatohepatitis in mice by decreasing lipogenic and inflammatory processes
Q36211215Salvage of nicotinamide adenine dinucleotide plays a critical role in the bioenergetic recovery of post-hypoxic cardiomyocytes
Q36016427Salvinorin A analogues PR-37 and PR-38 attenuate compound 48/80-induced itch responses in mice
Q35538502Schizandrin ameliorates ovariectomy-induced memory impairment, potentiates neurotransmission and exhibits antioxidant properties
Q38902193Selected ginsenosides of the protopanaxdiol series are novel positive allosteric modulators of P2X7 receptors.
Q34914184Selective Na(+) /Ca(2+) exchanger inhibition prevents Ca(2+) overload-induced triggered arrhythmias
Q37005123Selective activation of D1 dopamine receptors impairs sensorimotor gating in Long-Evans rats
Q35484295Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.
Q40920633Selective endothelin A receptor antagonism with sitaxentan reduces neointimal lesion size in a mouse model of intraluminal injury
Q34994502Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes
Q51010606Selectivity determinants of GPCR-G-protein binding.
Q35039209Serelaxin-mediated signal transduction in human vascular cells: bell-shaped concentration-response curves reflect differential coupling to G proteins
Q35538490Seven novel modulators of the analgesic target NaV 1.7 uncovered using a high-throughput venom-based discovery approach
Q36124212Sex hormones regulate cerebral drug metabolism via brain miRNAs: down-regulation of brain CYP2D by androgens reduces the analgesic effects of tramadol
Q40920761Short-term variability in QT interval and ventricular arrhythmias induced by dofetilide are dependent on high-frequency autonomic oscillations.
Q34795714Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in rats.
Q38247701Signalling pathways and mechanisms of protection in pre- and postconditioning: historical perspective and lessons for the future
Q40695320Simulating the influence of plasma protein on measured receptor affinity in biochemical assays reveals the utility of Schild analysis for estimating compound affinity for plasma proteins.
Q34914140Simulation with cells in vitro of tamoxifen treatment in premenopausal breast cancer patients with different CYP2D6 genotypes
Q35911736Simvastatin alleviates cardiac fibrosis induced by infarction via up-regulation of TGF-β receptor III expression
Q37686136Single administration of recombinant IL-6 restores the gene expression of lipogenic enzymes in liver of fasting IL-6-deficient mice.
Q28595808Size distribution of function-based human gene sets and the split-merge model
Q34954124Small-molecule modulators of the OX40-OX40 ligand co-stimulatory protein-protein interaction
Q35631474Sodium butyrate epigenetically modulates high-fat diet-induced skeletal muscle mitochondrial adaptation, obesity and insulin resistance through nucleosome positioning
Q34994524Sonic hedgehog increases the skin wound-healing ability of mouse embryonic stem cells through the microRNA 200 family
Q36533318Species-specific action of (Pro3)GIP - a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors
Q34939936Specific regions display altered grey matter volume in μ-opioid receptor knockout mice: MRI voxel-based morphometry
Q35865460Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys
Q34994554Spinal blockage of P/Q- or N-type voltage-gated calcium channels modulates functional and symptomatic changes related to haemorrhagic cystitis in mice.
Q35484468Stage-dependent benefits and risks of pimobendan in mice with genetic dilated cardiomyopathy and progressive heart failure
Q42700967State-dependent blocking mechanism of Kv 1.3 channels by the antimycobacterial drug clofazimine.
Q34440487Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in rats
Q35484280Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues
Q28274664Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R)
Q35692991Structural apelin analogues: mitochondrial ROS inhibition and cardiometabolic protection in myocardial ischaemia reperfusion injury
Q39145769Structural basis for constitutive activity and agonist-induced activation of the enteroendocrine fat sensor GPR119.
Q36336103Structural features embedded in G protein-coupled receptor co-crystal structures are key to their success in virtual screening
Q38877799Structural modeling of G-protein coupled receptors: An overview on automatic web-servers
Q38572969Structure-activity relationship studies of citalopram derivatives: examining substituents conferring selectivity for the allosteric site in the 5-HT transporter
Q36036218Structure-activity relationships of bumetanide derivatives: correlation between diuretic activity in dogs and inhibition of the human NKCC2A transporter
Q35223902Structure-function analysis of apical membrane-associated molecules of the tegument of schistosome parasites of humans: prospects for identification of novel targets for parasite control
Q38567235Superagonism at G protein-coupled receptors and beyond
Q35846195Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates.
Q58079602Survey of Similarity-based Prediction of Drug-protein Interactions
Q35484306Synergistic anti-tumour effects of tetrandrine and chloroquine combination therapy in human cancer: a potential antagonistic role for p21.
Q36314597Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions
Q38856978Synergistic effect of targeting the epidermal growth factor receptor and hyaluronan synthesis in oesophageal squamous cell carcinoma cells.
Q35111443Synthesis and SAR studies of novel 6,7,8-substituted 4-substituted benzyloxyquinolin-2(1H)-one derivatives for anticancer activity
Q34795679Synthetic (+)-antroquinonol exhibits dual actions against insulin resistance by triggering AMP kinase and inhibiting dipeptidyl peptidase IV activities
Q34619444Synthetic gestagens exert differential effects on arterial thrombosis and aortic gene expression in ovariectomized apolipoprotein E-deficient mice
Q41761883TRPC6 regulates cell cycle progression by modulating membrane potential in bone marrow stromal cells
Q43127401TRPM4 inhibitor 9-phenanthrol activates endothelial cell intermediate conductance calcium-activated potassium channels in rat isolated mesenteric artery
Q35223934TRPV4 and K(Ca) ion channels functionally couple as osmosensors in the paraventricular nucleus
Q34402827Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer.
Q38866310Targeting orphan G protein-coupled receptors for the treatment of diabetes and its complications: C-peptide and GPR146.
Q34994532Targeting the cis-dimerization of LINGO-1 with low MW compounds affects its downstream signalling
Q38231327Targeting the histone orthography of cancer: drugs for writers, erasers and readers
Q34994509Targeting two-pore domain K(+) channels TREK-1 and TASK-3 for the treatment of depression: a new therapeutic concept.
Q26849417Ten things you should know about protein kinases: IUPHAR Review 14
Q42594000Thalamic Kv 7 channels: pharmacological properties and activity control during noxious signal processing
Q35978150The Akt inhibitor, triciribine, ameliorates chronic hypoxia-induced vascular pruning and TGFβ-induced pulmonary fibrosis
Q35484349The Ca(2+) channel inhibitor 2-APB reverses β-amyloid-induced LTP deficit in hippocampus by blocking BAX and caspase-3 hyperactivation
Q37005139The D1CT-7 mouse model of Tourette syndrome displays sensorimotor gating deficits in response to spatial confinement
Q36903392The G-protein biased partial κ opioid receptor agonist 6'-GNTI blocks hippocampal paroxysmal discharges without inducing aversion.
Q35978114The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis
Q42594089The GPR55 agonist lysophosphatidylinositol relaxes rat mesenteric resistance artery and induces Ca(2+) release in rat mesenteric artery endothelial cells
Q89534525The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology
Q28603128The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
Q47139831The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.
Q91135369The IUPHAR/BPS Guide to PHARMACOLOGY in 2020: extending immunopharmacology content and introducing the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY
Q92999338The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases
Q60950964The Role of G Protein-Coupled Receptors in the Right Ventricle in Pulmonary Hypertension
Q41374415The TRPA1 channel mediates the analgesic action of dipyrone and pyrazolone derivatives
Q26770007The Warburg effect and drug resistance
Q41987929The activation of supraspinal GPR40/FFA1 receptor signalling regulates the descending pain control system
Q41963193The acute and long-term L-DOPA effects are independent from changes in the activity of dorsal raphe serotonergic neurons in 6-OHDA lesioned rats
Q37682000The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels
Q35911754The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT7 receptors.
Q42070708The behavioural response of mice lacking NK₁ receptors to guanfacine resembles its clinical profile in treatment of ADHD.
Q41865064The blockade of transient receptor potential ankirin 1 (TRPA1) signalling mediates antidepressant- and anxiolytic-like actions in mice
Q40559527The brain renin-angiotensin system plays a crucial role in regulating body weight in diet-induced obesity in rats
Q38258238The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism
Q38927458The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells
Q34914286The ceramide kinase inhibitor NVP-231 inhibits breast and lung cancer cell proliferation by inducing M phase arrest and subsequent cell death
Q38263517The contribution of astrocytes and microglia to traumatic brain injury
Q48347170The druggable genome and support for target identification and validation in drug development.
Q26822987The effects of microRNA on the absorption, distribution, metabolism and excretion of drugs
Q35538511The effects of sigma (σ1) receptor-selective ligands on muscarinic receptor antagonist-induced cognitive deficits in mice
Q41295964The endocannabinoid system in renal cells: regulation of Na(+) transport by CB1 receptors through distinct cell signalling pathways.
Q37682003The endocannabinoid system regulates synaptic transmission in nucleus accumbens by increasing DAGL-α expression following short-term morphine withdrawal
Q35631478The endoplasmic reticulum stress and the HIF-1 signalling pathways are involved in the neuronal damage caused by chemical hypoxia.
Q26801862The expanding role of immunopharmacology: IUPHAR Review 16
Q34042836The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies
Q37060125The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins
Q36506873The high frequency relationship: implications for torsadogenic hERG blockers
Q36342106The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases
Q35865433The long-acting β2 -adrenoceptor agonist olodaterol attenuates pulmonary inflammation.
Q39960078The long-acting β2 -adrenoceptor agonist, indacaterol, enhances glucocorticoid receptor-mediated transcription in human airway epithelial cells in a gene- and agonist-dependent manner
Q34509746The metabotropic glutamate 5 receptor is necessary for extinction of cocaine-associated cues.
Q34953451The neurosteroid 5β-pregnan-3α-ol-20-one enhances actions of etomidate as a positive allosteric modulator of α1β2γ2L GABAA receptors
Q34795703The non-peptide GLP-1 receptor agonist WB4-24 blocks inflammatory nociception by stimulating β-endorphin release from spinal microglia
Q36036250The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivo
Q41858391The novel nonapeptide acein targets angiotensin converting enzyme in the brain and induces dopamine release
Q36506869The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity
Q35978068The opioid receptors as targets for drug abuse medication
Q35538538The orally active urotensin receptor antagonist, KR36676, attenuates cellular and cardiac hypertrophy
Q28581148The orphan receptor NOR1 participates in isoprenaline-induced cardiac hypertrophy by regulating PARP-1
Q38273378The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges.
Q36903406The pharmacodynamics, safety and pharmacokinetics of single doses of the motilin agonist, camicinal, in type 1 diabetes mellitus with slow gastric emptying
Q35111468The phytocannabinoid, Δ⁹-tetrahydrocannabivarin, can act through 5-HT₁A receptors to produce antipsychotic effects.
Q36830111The pregnane X receptor down-regulates organic cation transporter 1 (SLC22A1) in human hepatocytes by competing for ("squelching") SRC-1 coactivator
Q36744197The proton-coupled oligopeptide transporter 1 plays a major role in the intestinal permeability and absorption of 5-aminolevulinic acid
Q34795724The role of adenylyl cyclase isoform 6 in β-adrenoceptor signalling in murine airways
Q28085261The role of cannabinoids in adult neurogenesis
Q26825733The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning
Q38247510The role of hexokinase in cardioprotection - mechanism and potential for translation
Q41762813The role of metformin and resveratrol in the prevention of hypoxia-inducible factor 1α accumulation and fibrosis in hypoxic adipose tissue
Q34939699The role of opioid processes in reward and decision-making
Q27021287The role of phosphoinositide-regulated actin reorganization in chemotaxis and cell migration
Q43119916The sGC stimulator riociguat inhibits platelet function in washed platelets but not in whole blood
Q41958515The sphingosine 1-phosphate receptor agonist FTY720 is neuroprotective after cuprizone-induced CNS demyelination
Q37686313The tyrosine kinase inhibitor dasatinib reduces lung inflammation and remodelling in experimental allergic asthma.
Q36342116The virtual heart as a platform for screening drug cardiotoxicity
Q43127407Therapeutic action of 5-HT3 receptor antagonists targeting peritoneal macrophages in post-operative ileus
Q34427050Therapeutic interventions in sepsis: current and anticipated pharmacological agents
Q35631468Therapeutic perspectives of epigenetically active nutrients.
Q36434850Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information
Q28081591Therapeutic targets of triple-negative breast cancer: a review
Q36830120Therapeutic time window for angiotensin-(1-7) in acute lung injury
Q34419654Therapeutic use of botulinum toxin in migraine: mechanisms of action
Q36506899Threonine532 phosphorylation in ClC-3 channels is required for angiotensin II-induced Cl(-) current and migration in cultured vascular smooth muscle cells
Q37686150Time-dependent activation of prostacyclin and nitric oxide pathways during continuous i.v. infusion of serelaxin (recombinant human H2 relaxin)
Q36124220Tissue-specific up-regulation of arginase I and II induced by p38 MAPK mediates endothelial dysfunction in type 1 diabetes mellitus
Q35846211Toll-interacting protein contributes to mortality following myocardial infarction through promoting inflammation and apoptosis
Q42593944Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension
Q35974649Topology based identification and comprehensive classification of four-transmembrane helix containing proteins (4TMs) in the human genome
Q39034639Toward the next step in G protein-coupled receptor research: a knowledge-driven analysis for the next potential targets in drug discovery.
Q35484265Transdermal patches: history, development and pharmacology.
Q39963734Translational mixed-effects PKPD modelling of recombinant human growth hormone - from hypophysectomized rat to patients.
Q34619478Treatment with LPS plus INF-γ induces the expression and function of muscarinic acetylcholine receptors, modulating NIH3T3 cell proliferation: participation of NOS and COX.
Q34914207Treatment with melatonin after onset of experimental uveitis attenuates ocular inflammation.
Q36797382Trimetazidine does not alter metabolic substrate oxidation in cardiac mitochondria of target patient population.
Q36506880Trimetazidine prevents macrophage-mediated septic myocardial dysfunction via activation of the histone deacetylase sirtuin 1
Q34994529Tubulin acetylation promoting potency and absorption efficacy of deacetylase inhibitors.
Q38400921Twenty years of the MEROPS database of proteolytic enzymes, their substrates and inhibitors.
Q34402789Ulinastatin activates haem oxygenase 1 antioxidant pathway and attenuates allergic inflammation
Q38768616Ultra-rare genetic variation in common epilepsies: a case-control sequencing study
Q35161111Unravelling the theories of pre-eclampsia: are the protective pathways the new paradigm?
Q28308192Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7
Q35223911Urinary bladder inflammation induces changes in urothelial nerve growth factor and TRPV1 channels
Q38973928Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF-β1/Smad2/3 signalling
Q35978134Validating the GTP-cyclohydrolase 1-feedback regulatory complex as a therapeutic target using biophysical and in vivo approaches
Q37441534Valproic acid protects against haemorrhagic shock-induced signalling changes via PPARγ activation in an in vitro model
Q34402797Vasorelaxant effects of novel Kv 7.4 channel enhancers ML213 and NS15370
Q92355875Visualization of drug target interactions in the contexts of pathways and networks with ReactomeFIViz
Q38927398WMJ-S-001, a novel aliphatic hydroxamate derivative, exhibits anti-inflammatory properties via MKP-1 in LPS-stimulated RAW264.7 macrophages
Q36124216WTC-01, a novel synthetic oxime-flavone compound, destabilizes microtubules in human nasopharyngeal carcinoma cells in vitro and in vivo
Q26998084What can isolated skeletal muscle experiments tell us about the effects of caffeine on exercise performance?
Q38646773What is the evidence for the role of TRP channels in inflammatory and immune cells?
Q46020276Why Data Citation Is a Computational Problem.
Q104213849Wikidata as a FAIR knowledge graph for the life sciences
Q87830400Wikidata as a knowledge graph for the life sciences
Q34795766YM155 down-regulates survivin and XIAP, modulates autophagy and induces autophagy-dependent DNA damage in breast cancer cells
Q35865429Zolpidem and eszopiclone prime α1β2γ2 GABAA receptors for longer duration of activity
Q35846216cAMP-dependent activation of protein kinase A as a therapeutic target of skin hyperpigmentation by diphenylmethylene hydrazinecarbothioamide
Q27001653p38 MAPK in cardioprotection - are we there yet?
Q35223945Δ(9) Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells
Q41373553α-Galactosylceramide suppresses murine eosinophil production through interferon-γ-dependent induction of NO synthase and CD95.
Q42356377α1 -Adrenoceptor activation of PKC-ε causes heterologous desensitization of thromboxane receptors in the aorta of spontaneously hypertensive rats
Q37686129α1B -Adrenoceptor signalling regulates bone formation through the up-regulation of CCAAT/enhancer-binding protein δ expression in osteoblasts.
Q42176718α7 nicotinic ACh receptor-deficient mice exhibit sustained attention impairments that are reversed by β2 nicotinic ACh receptor activation
Q37084535β-Arrestin 2 dependence of δ opioid receptor agonists is correlated with alcohol intake
Q36211207β-Blockers have differential effects on the murine asthma phenotype
Q38849244δ Subunit-containing GABAA receptors are preferred targets for the centrally acting analgesic flupirtine.
Q41813091δ-Opioid receptors up-regulate excitatory amino acid transporters in mouse astrocytes
Q35039212κ-Opioid receptors are not necessary for the antidepressant treatment of neuropathic pain
Q34914351σ1 receptors activate astrocytes via p38 MAPK phosphorylation leading to the development of mechanical allodynia in a mouse model of neuropathic pain

Search more.